The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 14,232 | 337,000 | SH | SOLE | 337,000 | 0 | 0 | ||
| ACCELERON PHARMA INC | COM | 00434H108 | 1,617 | 18,000 | SH | SOLE | 18,000 | 0 | 0 | ||
| Agios Pharmaceuticals Inc | COM | 00847X104 | 762 | 21,500 | SH | SOLE | 21,500 | 0 | 0 | ||
| Alexion Pharmaceuticals Inc | COM | 015351109 | 6,611 | 73,641 | SH | SOLE | 73,641 | 0 | 0 | ||
| ALKERMES PLC | SHS | G01767105 | 749 | 52,000 | SH | SOLE | 52,000 | 0 | 0 | ||
| ALLAKOS INC | COM | 01671P100 | 692 | 15,700 | SH | SOLE | 15,700 | 0 | 0 | ||
| Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 2,425 | 22,300 | SH | SOLE | 22,300 | 0 | 0 | ||
| Amarin Corp Plc | SPONS ADR NEW | 023111206 | 1,274 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
| Amgen Inc | COM | 031162100 | 13,380 | 66,000 | SH | SOLE | 66,000 | 0 | 0 | ||
| Amicus Therapeutics Inc | COM | 03152W109 | 873 | 94,600 | SH | SOLE | 94,600 | 0 | 0 | ||
| ANAPTYSBIO INC | COM | 032724106 | 140 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| Arena Pharmaceuticals Inc | COM | 040047607 | 690 | 16,500 | SH | SOLE | 16,500 | 0 | 0 | ||
| Ascendis Pharma AS | Sponsored ADR | 04351P101 | 1,548 | 13,800 | SH | SOLE | 13,800 | 0 | 0 | ||
| Biogen Inc | COM | 09062X103 | 14,458 | 45,700 | SH | SOLE | 45,700 | 0 | 0 | ||
| Biomarin Pharmaceutical Inc | COM | 09061G101 | 14,338 | 169,784 | SH | SOLE | 169,784 | 0 | 0 | ||
| Bluebird Bio Inc | COM | 09609G100 | 505 | 11,000 | SH | SOLE | 11,000 | 0 | 0 | ||
| Blueprint Medicines Corp | COM | 09627Y109 | 700 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 930 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | ||
| CHEMOCENTRYX INC | COM | 16383L106 | 7,629 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS INC | COM | 24344T101 | 697 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | ||
| LILLY ELI & CO | COM | 532457108 | 2,770 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 2,385 | 46,500 | SH | SOLE | 46,500 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 298 | 9,500 | SH | SOLE | 9,500 | 0 | 0 | ||
| Exact Sciences Corp | COM | 30063P105 | 619 | 10,700 | SH | SOLE | 10,700 | 0 | 0 | ||
| Exelixis Inc | COM | 30161Q104 | 1,776 | 103,534 | SH | SOLE | 103,534 | 0 | 0 | ||
| FibroGen Inc | COM | 31572Q808 | 684 | 19,700 | SH | SOLE | 19,700 | 0 | 0 | ||
| GW Pharmaceuticals Plc | ADS | 36197T103 | 893 | 10,200 | SH | SOLE | 10,200 | 0 | 0 | ||
| Gilead Sciences Inc | COM | 375558103 | 17,718 | 237,284 | SH | SOLE | 237,284 | 0 | 0 | ||
| Global Blood Therapeutics | COM | 37890U108 | 498 | 9,800 | SH | SOLE | 9,800 | 0 | 0 | ||
| Halozyme Therapeutics Inc | COM | 40637H109 | 5,531 | 307,633 | SH | SOLE | 307,633 | 0 | 0 | ||
| HORIZON THERAPEUTICS PUB LTD | SHS | G46188101 | 11,662 | 394,000 | SH | SOLE | 394,000 | 0 | 0 | ||
| IMMUNOMEDICS INC | COM | 452907108 | 970 | 72,000 | SH | SOLE | 72,000 | 0 | 0 | ||
| Incyte Corp | COM | 45337C102 | 7,286 | 99,500 | SH | SOLE | 99,500 | 0 | 0 | ||
| INSMED INC | COM | 457669307 | 537 | 33,600 | SH | SOLE | 33,600 | 0 | 0 | ||
| INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 352 | 23,000 | SH | SOLE | 23,000 | 0 | 0 | ||
| Ionis Pharmaceuticals Inc | COM | 462222100 | 2,543 | 53,781 | SH | SOLE | 53,781 | 0 | 0 | ||
| Kalvista Pharmaceuticals Inc | COM | 483497103 | 381 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| Kalvista Pharmaceuticals Inc | COM | 483497103 | 1,350 | 177,433 | SH | SOLE | 177,433 | 0 | 0 | ||
| MERCK & CO INC | COM | 58933Y105 | 6,403 | 83,200 | SH | SOLE | 83,200 | 0 | 0 | ||
| Millendo Therapeutics Inc | COM | 60040X103 | 939 | 177,825 | SH | SOLE | 177,825 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 3,374 | 43,900 | SH | SOLE | 43,900 | 0 | 0 | ||
| MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 734 | 27,000 | SH | SOLE | 27,000 | 0 | 0 | ||
| Myokardia INC | COM | 62857M105 | 743 | 15,859 | SH | SOLE | 15,859 | 0 | 0 | ||
| NEKTAR THERAPEUTICS | COM | 640268108 | 1,193 | 67,000 | SH | SOLE | 67,000 | 0 | 0 | ||
| Neurocrine Biosciences Inc | COM | 64125C109 | 9,288 | 107,300 | SH | SOLE | 107,300 | 0 | 0 | ||
| PTC Therapuetics COM | COM | 69366J200 | 11,971 | 269,000 | SH | SOLE | 269,000 | 0 | 0 | ||
| PRINCIPIA BIOPHARMA INC | COM | 74257L108 | 1,351 | 23,100 | SH | SOLE | 23,100 | 0 | 0 | ||
| Sage Therapeutics Inc | COM | 78667J108 | 1,077 | 37,600 | SH | SOLE | 37,600 | 0 | 0 | ||
| Sarepta Therapeutics Inc | COM | 803607100 | 2,744 | 28,100 | SH | SOLE | 28,100 | 0 | 0 | ||
| Seattle Genetics Inc | COM | 812578102 | 6,557 | 56,900 | SH | SOLE | 56,900 | 0 | 0 | ||
| SUTRO BIOPHARMA INC | COM | 869367102 | 1,375 | 139,331 | SH | SOLE | 139,331 | 0 | 0 | ||
| Tricida Inc | COM | 89610F101 | 635 | 29,000 | SH | SOLE | 29,000 | 0 | 0 | ||
| TURNING POINT THERAPEUTICS I | COM | 90041T108 | 1,542 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | 1,289 | 27,500 | SH | SOLE | 27,500 | 0 | 0 | ||
| Vertex Pharmaceuticals Inc | COM | 92532F100 | 18,517 | 77,822 | SH | SOLE | 77,822 | 0 | 0 | ||
| ZEALAND PHARMA A S | SPONSORED ADR | 98920Y304 | 183 | 5,653 | SH | SOLE | 5,653 | 0 | 0 | ||
| Zogenix Inc | COM | 98978L204 | 6,955 | 281,797 | SH | SOLE | 281,797 | 0 | 0 | ||